Social ecological influences on treatment decision-making in men diagnosed with low risk, localised prostate cancer

被引:3
|
作者
McIntosh, Megan [1 ,2 ,3 ]
Opozda, Melissa J. [2 ,3 ]
Short, Camille E. [4 ,5 ]
Galvao, Daniel A. [6 ]
Tutino, Rebecca [7 ]
Diefenbach, Michael [8 ]
Ehdaie, Behfar [7 ]
Nelson, Christian [7 ]
机构
[1] Univ Adelaide, Fac Hlth & Med Sci, Sch Med, Adelaide, SA, Australia
[2] South Australian Hlth & Med Res Inst, Freemasons Ctr Male Hlth & Wellbeing, Adelaide, SA, Australia
[3] Univ Adelaide, Adelaide, SA, Australia
[4] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia
[5] Univ Melbourne, Melbourne Sch Hlth Sci, Melbourne, Vic, Australia
[6] Edith Cowan Univ, Exercise Med Res Inst, Joondalup, WA, Australia
[7] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[8] Northwell Hlth, New Hyde Pk, NY USA
关键词
active surveillance; decision-making; prostate cancer; qualitative research; supportive care; treatment decision-making; ACTIVE SURVEILLANCE; PARTNERS;
D O I
10.1111/ecc.13697
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Individuals diagnosed with low risk, localised prostate cancer (PCa) face a difficult decision between active surveillance (AS) and definitive treatment. We aimed to explore perceived influences on treatment decision-making from the patient and partner's perspectives. Methods Patients (and partners) who met AS criteria and had chosen their treatment were recruited. Semi-structured individual interviews were conducted via telephone to explore experiences of diagnosis, impact on patient lifestyle, experiences with physicians, treatment preferences/choice, treatment information understanding and needs, and overall decision-making process. Interviews were audio recorded, transcribed verbatim, and analysed using Reflexive Thematic Analysis. Results Twenty-four male patients (18 chose AS) and 12 female partners participated. Five themes relating to social-ecological influences on treatment choice were identified: (1) partner support and direct influence on patient treatment choice, (2) patient and partner vicarious experiences may influence treatment decisions, (3) the influence of the patient's life circumstances, (4) disclosing to wider social networks: friends, family, and co-workers, and (5) the importance of a good relationship and experience with physicians. Additionally, two themes were identified relating to information patients and partners received about the treatment options during their decision-making process. Conclusions A range of individual and social influences on treatment decision-making were reported. Physicians providing treatment recommendations should consider and discuss the patient and partner's existing beliefs and treatment preferences and encourage shared decision-making. Further research on treatment decision-making of partnered and non-partnered PCa patients is required. We recommend research considers social ecological factors across the personal, interpersonal, community, and policy levels.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Australian men with low risk prostate cancer and their partners' experience of treatment decision-making and active surveillance
    Hyatt, Amelia
    O' Callaghan, Clare
    Dryden, Tracey
    Burney, Sue
    Wootten, Addie
    Brooker, Joanne
    Fletcher, Jane
    Frydenberg, Mark
    Murphy, Declan
    White, Alan
    Schofiled, Penelope
    [J]. BJU INTERNATIONAL, 2013, 112 : 64 - 64
  • [2] Patient centeredness and decision-making in localised prostate cancer
    Huber, J.
    Ihrig, A.
    Huber, C. G.
    Hadaschik, B.
    Pahernik, S.
    Hohenfellner, M.
    [J]. UROLOGE, 2011, 50 (06): : 691 - 696
  • [3] Patient participation in the decision-making process of localised prostate cancer treatment-the decision-making role of the patient
    Wang, Luke
    Ranasinghe, Weranja
    [J]. BJU INTERNATIONAL, 2016, 118 : 13 - 13
  • [4] Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer
    Davis, Kimberly
    Bellini, Paula
    Hagerman, Charlotte
    Zinar, Riley
    Leigh, Daniel
    Hoffman, Richard
    Aaronson, David
    Van den Eeden, Stephen
    Philips, George
    Taylor, Kathryn
    [J]. UROLOGY, 2017, 107 : 86 - 94
  • [5] Selecting Active Surveillance: Decision-Making Factors for Men with a Low-Risk Prostate Cancer
    Hoffman, Richard M.
    Lobo, Tania
    Van Den Eeden, Stephen K.
    Davis, Kimberly M.
    Luta, George
    Leimpeter, Amethyst D.
    Aaronson, David
    Penson, David F.
    Taylor, Kathryn
    [J]. MEDICAL DECISION MAKING, 2019, 39 (08) : 962 - 974
  • [6] SELECTING ACTIVE SURVEILLANCE: DECISION-MAKING FACTORS FOR MEN WITH A LOW-RISK PROSTATE CANCER
    Hoffman, Richard M.
    Lobo, Tania
    Van den Eeden, Stephen K.
    Luta, George
    Davis, Kimberly M.
    Aaronsen, David
    Taylor, Kathryn L.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S336 - S336
  • [7] Decision-making processes among men with low-risk prostate cancer: A survey study
    Hoffman, Richard M.
    Van den Eeden, Stephen K.
    Davis, Kimberly M.
    Lobo, Tania
    Luta, George
    Shan, Jun
    Aaronson, David
    Penson, David F.
    Leimpeter, Amethyst D.
    Taylor, Kathryn L.
    [J]. PSYCHO-ONCOLOGY, 2018, 27 (01) : 325 - 332
  • [8] Influence of Men's Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer
    Reamer, Elyse
    Yang, Felix
    Holmes-Rovner, Margaret
    Liu, Joe
    Xu, Jinping
    [J]. BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [9] Development of navigate: an online treatment decision aid for men diagnosed with low risk prostate cancer
    Schofield, Penelope
    Hyatt, Amelia
    Chambers, Suzanne K.
    Cavedon, Lawrence
    White, Alan
    Frydenberg, Mark
    Murphy, Declan
    Brooker, Joanne
    Gardiner, Frank
    Gordon, Louisa
    Coughlin, Geoffrey
    Millar, Jeremy
    Grummet, Jeremy
    Yaxley, John
    Lawrentschuk, Nathan
    Juraskova, Ilona
    [J]. BJU INTERNATIONAL, 2016, 118 : 40 - 40
  • [10] Patient Decision-Making Factors in Aggressive Treatment of Low-Risk Prostate Cancer
    Basak, Ramsankar
    Usinger, Deborah S.
    Chen, Ronald C.
    Shen, Xinglei
    [J]. JNCI CANCER SPECTRUM, 2022, 6 (01)